Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Rodman David Malcom sold 417 Mineralys Therapeutics, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 19, 2026
On May 18, 2026, Rodman David Malcom (Chief Medical Officer) sold 417 Mineralys Therapeutics, Inc. shares at US$27.55 for US$11,488 under a trading plan, leaving 63,443 shares. Filed May 19, 2026 (Form 4).
- Sold
- 417 shares
- Price
- US$27.55
- Value
- US$11,488
- Holding after
- 63,443 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Option exercise | 417 | US$15.44 | 63,860 | Direct |
| May 18, 2026 | Common Stock | Sale | 417 | US$27.55 | 63,443 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Rodman David Malcom
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Rodman David Malcom · Aug 12, 2026
- Form 4 · Rodman David Malcom · Jul 20, 2026
- Form 4 · Rodman David Malcom · Jul 15, 2026
- Form 4 · Rodman David Malcom · Jul 10, 2026
- Form 4 · Rodman David Malcom · Jun 17, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026
- Form 4 · Karydas Daphne · Sep 17, 2026
- Form 4 · Warren Eric · Aug 25, 2026